VIPER® Platform Technology
See how Detact Diagnostics® patented, innovative VIPER® platform technology changes the bacterial, viral and fungal detection world.
VIPER® technology
The strength of the company lies in its patented platform technology.
The proprietary VIPER® (Visualisation by Infrared PEptide Reaction) technology enables the detection of pathogens or contaminating proteases by detecting the release of a Near-Infrared (NIR) fluorescent (light) signal from a peptide (molecule) when the target is present in a sample.
VIPER® is a modular technology that can be tuned to specific needs to directly detect bacteria, viruses, and fungi.
VIPER® v Competition
VIPER® empowers healthcare professionals and patients by combining a direct active bacteria detection solution with a fast, point-of-care detection solution. This contributes towards sustaining a healthy living.
Patent Portfolio Metrics
Detact Diagnostics' extensive Patent Portfolio includes 51 patent rights across 6 Patent families.
Our Patent families cover products, medical uses and methods of diagnostics covered.
Currently, we have protection until 2041.
